Novogene(SH:688315) Xin Lang Cai Jing·2025-07-15 09:57Core Viewpoint - The announcement details the share reduction results of the shareholders of Nuohe Zhiyuan, specifically Beijing Zhiyuan Hegu Investment Management Center and Beijing Nuohe Hegu Investment Management Center, outlining their shareholding changes and reduction plans [1][3]. Shareholding Situation Before Reduction - Before the reduction plan, Zhiyuan Hegu held 47,106,622 shares, accounting for 11.32% of the total shares of Nuohe Zhiyuan. Nuohe Hegu held 12,564,672 shares, representing 3.02% of the total shares. Together, they held 59,671,294 shares, which is 14.34% of the total shares, all acquired before the company's initial public offering and set to be tradable from April 15, 2024 [2]. Reduction Plan and Implementation Results - On March 20, 2025, Nuohe Zhiyuan disclosed a reduction plan, where Zhiyuan Hegu and Nuohe Hegu planned to reduce a total of up to 12,486,000 shares, representing 3% of the total shares. This included a maximum of 4,162,000 shares through centralized bidding (up to 1%) and 8,324,000 shares through block trading (up to 2%). As of July 15, 2025, they had reduced 2,898,677 shares through centralized bidding (0.70% of total shares) and 5,179,000 shares through block trading. The total reduction completed was 8,077,677 shares, or 1.94% of total shares, with a reduction price range of 12.83 to 14.99 yuan per share, totaling 110,264,756.78 yuan. Post-reduction, they held a combined total of 51,593,617 shares, which is 12.40% of the total shares [3].